• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预处理间充质干细胞通过提高存活率和植入率改善大鼠肾缺血性损伤。

Pre-conditioned mesenchymal stem cells ameliorate renal ischemic injury in rats by augmented survival and engraftment.

机构信息

National Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan.

出版信息

J Transl Med. 2012 Dec 5;10:243. doi: 10.1186/1479-5876-10-243.

DOI:10.1186/1479-5876-10-243
PMID:23217165
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3543338/
Abstract

BACKGROUND

Ischemia is the major cause of acute kidney injury (AKI), associated with high mortality and morbidity. Mesenchymal stem cells (MSCs) have multilineage differentiation potential and can be a potent therapeutic option for the cure of AKI.

METHODS

MSCs were cultured in four groups SNAP (S-nitroso N-acetyl penicillamine), SNAP + Methylene Blue (MB), MB and a control for in vitro analysis. Cultured MSCs were pre-conditioned with either SNAP (100 μM) or MB (1 μM) or both for 6 hours. Renal ischemia was induced in four groups (as in in vitro study) of rats by clamping the left renal padicle for 45 minutes and then different pre-conditioned stem cells were transplanted.

RESULTS

We report that pre-conditioning of MSCs with SNAP enhances their proliferation, survival and engraftment in ischemic kidney. Rat MSCs pre-conditioned with SNAP decreased cell apoptosis and increased proliferation and cytoprotective genes' expression in vitro. Our in vivo data showed enhanced survival and engraftment, proliferation, reduction in fibrosis, significant improvement in renal function and higher expression of pro-survival and pro-angiogenic factors in ischemic renal tissue in SNAP pre-conditioned group of animals. Cytoprotective effects of SNAP pre-conditioning were abrogated by MB, an inhibitor of nitric oxide synthase (NOS) and guanylate cyclase.

CONCLUSION

The results of these studies demonstrate that SNAP pre-conditioning might be useful to enhance therapeutic potential of MSCs in attenuating renal ischemia reperfusion injury.

摘要

背景

缺血是急性肾损伤(AKI)的主要原因,与高死亡率和发病率相关。间充质干细胞(MSCs)具有多能分化潜能,是治疗 AKI 的有效治疗方法。

方法

将 MSCs 在 SNAP(S-亚硝基-N-乙酰青霉胺)、SNAP+亚甲蓝(MB)、MB 和对照 4 组中进行培养,用于体外分析。将培养的 MSCs 用 SNAP(100 μM)或 MB(1 μM)或两者预处理 6 小时。通过夹闭左肾蒂 45 分钟,在 4 组大鼠(如体外研究)中诱导肾缺血,然后移植不同预处理的干细胞。

结果

我们报告说,用 SNAP 预处理 MSC 可增强其在缺血肾脏中的增殖、存活和定植。体外 SNAP 预处理的大鼠 MSCs 减少了细胞凋亡,增加了增殖和细胞保护基因的表达。我们的体内数据显示,SNAP 预处理组动物的存活率和定植率增加,增殖减少,纤维化减少,肾功能显著改善,缺血肾组织中促生存和促血管生成因子的表达增加。NOS(一氧化氮合酶)和鸟苷酸环化酶抑制剂 MB 可消除 SNAP 预处理的细胞保护作用。

结论

这些研究的结果表明,SNAP 预处理可能有助于增强 MSCs 在减轻肾缺血再灌注损伤中的治疗潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d28/3543338/af5a59683dec/1479-5876-10-243-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d28/3543338/18aa5fd6e678/1479-5876-10-243-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d28/3543338/869141e99908/1479-5876-10-243-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d28/3543338/eac239c4acf0/1479-5876-10-243-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d28/3543338/43a2b7295356/1479-5876-10-243-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d28/3543338/af5a59683dec/1479-5876-10-243-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d28/3543338/18aa5fd6e678/1479-5876-10-243-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d28/3543338/869141e99908/1479-5876-10-243-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d28/3543338/eac239c4acf0/1479-5876-10-243-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d28/3543338/43a2b7295356/1479-5876-10-243-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d28/3543338/af5a59683dec/1479-5876-10-243-5.jpg

相似文献

1
Pre-conditioned mesenchymal stem cells ameliorate renal ischemic injury in rats by augmented survival and engraftment.预处理间充质干细胞通过提高存活率和植入率改善大鼠肾缺血性损伤。
J Transl Med. 2012 Dec 5;10:243. doi: 10.1186/1479-5876-10-243.
2
Bone marrow-derived mesenchymal stem cells protect against cisplatin-induced acute kidney injury in rats by inhibiting cell apoptosis.骨髓间充质干细胞通过抑制细胞凋亡来保护大鼠顺铂诱导的急性肾损伤。
Int J Mol Med. 2013 Dec;32(6):1262-72. doi: 10.3892/ijmm.2013.1517. Epub 2013 Oct 8.
3
3D spheroid culture enhances survival and therapeutic capacities of MSCs injected into ischemic kidney.3D球体培养可提高注入缺血性肾脏的间充质干细胞的存活率和治疗能力。
J Cell Mol Med. 2016 Jul;20(7):1203-13. doi: 10.1111/jcmm.12651. Epub 2016 Feb 24.
4
Microvesicles derived from human Wharton's Jelly mesenchymal stromal cells ameliorate renal ischemia-reperfusion injury in rats by suppressing CX3CL1.源自人脐带华通氏胶间充质基质细胞的微泡通过抑制CX3CL1改善大鼠肾缺血再灌注损伤。
Stem Cell Res Ther. 2014 Mar 19;5(2):40. doi: 10.1186/scrt428.
5
Hypoxic mesenchymal stem cells ameliorate acute kidney ischemia-reperfusion injury via enhancing renal tubular autophagy.低氧间充质干细胞通过增强肾小管自噬改善急性肾缺血再灌注损伤。
Stem Cell Res Ther. 2021 Jun 28;12(1):367. doi: 10.1186/s13287-021-02374-x.
6
Integrin receptor-binding nanofibrous peptide hydrogel for combined mesenchymal stem cell therapy and nitric oxide delivery in renal ischemia/reperfusion injury.整合素受体结合的纳米纤维肽水凝胶用于肾缺血/再灌注损伤中的骨髓间充质干细胞治疗和一氧化氮递送的联合治疗。
Stem Cell Res Ther. 2022 Jul 26;13(1):344. doi: 10.1186/s13287-022-03045-1.
7
Human mesenchymal stromal cells ameliorate complement induced inflammatory cascade and improve renal functions in a rat model of ischemia-reperfusion induced acute kidney injury.人骨髓间充质基质细胞改善补体诱导的炎症级联反应,并改善缺血再灌注诱导的急性肾损伤大鼠模型的肾功能。
PLoS One. 2019 Sep 12;14(9):e0222354. doi: 10.1371/journal.pone.0222354. eCollection 2019.
8
The use of chitosan based hydrogel for enhancing the therapeutic benefits of adipose-derived MSCs for acute kidney injury.壳聚糖基水凝胶在增强脂肪来源间充质干细胞治疗急性肾损伤中的治疗效果的应用。
Biomaterials. 2012 May;33(14):3673-81. doi: 10.1016/j.biomaterials.2012.01.061. Epub 2012 Feb 21.
9
Hypoxia-pretreated human MSCs attenuate acute kidney injury through enhanced angiogenic and antioxidative capacities.缺氧预处理的人骨髓间充质干细胞通过增强血管生成和抗氧化能力减轻急性肾损伤。
Biomed Res Int. 2014;2014:462472. doi: 10.1155/2014/462472. Epub 2014 Jul 16.
10
Nestin(+) kidney resident mesenchymal stem cells for the treatment of acute kidney ischemia injury.巢蛋白(+)肾脏固有间充质干细胞治疗急性肾缺血损伤。
Biomaterials. 2015 May;50:56-66. doi: 10.1016/j.biomaterials.2015.01.029. Epub 2015 Feb 14.

引用本文的文献

1
Enhanced reno-protective effects of CHIR99021 modified mesenchymal stem cells against rat acute kidney injury model.CHIR99021修饰的间充质干细胞对大鼠急性肾损伤模型的增强肾保护作用。
Bioimpacts. 2024 Nov 4;15:30600. doi: 10.34172/bi.30600. eCollection 2025.
2
Advances in the Treatment of Kidney Disorders using Mesenchymal Stem Cells.间充质干细胞治疗肾脏疾病的研究进展。
Curr Pharm Des. 2024;30(11):825-840. doi: 10.2174/0113816128296105240305110312.
3
Optimization strategies of mesenchymal stem cell-based therapy for acute kidney injury.

本文引用的文献

1
Growth factor preconditioning increases the function of diabetes-impaired mesenchymal stem cells.生长因子预处理可提高糖尿病损伤间充质干细胞的功能。
Stem Cells Dev. 2011 Jan;20(1):67-75. doi: 10.1089/scd.2009.0397. Epub 2010 Oct 12.
2
The BCL-2 family reunion.BCL-2 家族团聚。
Mol Cell. 2010 Feb 12;37(3):299-310. doi: 10.1016/j.molcel.2010.01.025.
3
Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab.贝伐单抗靶向血管内皮生长因子依赖性癌细胞的跨内皮迁移。
基于间充质干细胞的急性肾损伤治疗的优化策略。
Stem Cell Res Ther. 2023 Apr 30;14(1):116. doi: 10.1186/s13287-023-03351-2.
4
Mesenchymal Stem Cell Therapy in Kidney Diseases: Potential and Challenges.间质干细胞治疗肾脏疾病:潜力与挑战。
Cell Transplant. 2023 Jan-Dec;32:9636897231164251. doi: 10.1177/09636897231164251.
5
A review on renal autologous cell transplantation: an investigational approach towards chronic kidney disease.肾自体细胞移植的综述:一种针对慢性肾病的研究方法。
Int Urol Nephrol. 2023 Oct;55(10):2539-2544. doi: 10.1007/s11255-023-03574-5. Epub 2023 Mar 27.
6
Enhancing the Therapeutic Potential of Mesenchymal Stromal Cell-Based Therapies with an Anti-Fibrotic Agent for the Treatment of Chronic Kidney Disease.用抗纤维化药物增强间充质基质细胞疗法的治疗潜力,用于治疗慢性肾脏病。
Int J Mol Sci. 2022 May 27;23(11):6035. doi: 10.3390/ijms23116035.
7
Therapeutic Effects of Stem Cells From Different Source on Renal Ischemia- Reperfusion Injury: A Systematic Review and Network Meta-analysis of Animal Studies.不同来源干细胞对肾缺血再灌注损伤的治疗作用:动物研究的系统评价和网状Meta分析
Front Pharmacol. 2021 Sep 2;12:713059. doi: 10.3389/fphar.2021.713059. eCollection 2021.
8
The combination of G-CSF and AMD3100 mobilizes bone marrow-derived stem cells to protect against cisplatin-induced acute kidney injury in mice.G-CSF 和 AMD3100 的联合应用可动员骨髓源性干细胞以防止顺铂诱导的小鼠急性肾损伤。
Stem Cell Res Ther. 2021 Mar 24;12(1):209. doi: 10.1186/s13287-021-02268-y.
9
Stem cells: a potential treatment option for kidney diseases.干细胞:肾脏疾病的潜在治疗选择。
Stem Cell Res Ther. 2020 Jun 25;11(1):249. doi: 10.1186/s13287-020-01751-2.
10
Preconditioning is an effective strategy for improving the efficiency of mesenchymal stem cells in kidney transplantation.预处理是提高肾移植中间充质干细胞效率的有效策略。
Stem Cell Res Ther. 2020 May 24;11(1):197. doi: 10.1186/s13287-020-01721-8.
Mol Oncol. 2010 Apr;4(2):150-60. doi: 10.1016/j.molonc.2010.01.002. Epub 2010 Jan 7.
4
Repair of senescent myocardium by mesenchymal stem cells is dependent on the age of donor mice.间充质干细胞修复衰老心肌依赖于供体小鼠的年龄。
J Cell Mol Med. 2011 Jul;15(7):1515-27. doi: 10.1111/j.1582-4934.2009.00998.x. Epub 2009 Dec 11.
5
Poor cell survival limits the beneficial impact of mesenchymal stem cell transplantation on acute kidney injury.细胞存活率低限制了间充质干细胞移植对急性肾损伤的有益影响。
Nephron Exp Nephrol. 2010;114(3):e107-16. doi: 10.1159/000262318. Epub 2009 Dec 2.
6
Is there such a thing as a renal stem cell?存在肾干细胞这样的东西吗?
J Am Soc Nephrol. 2009 Oct;20(10):2112-7. doi: 10.1681/ASN.2009010066. Epub 2009 Aug 27.
7
The CXCL12 (SDF-1)/CXCR4 axis is essential for the development of renal vasculature.CXCL12(基质细胞衍生因子-1)/CXCR4轴对于肾血管系统的发育至关重要。
J Am Soc Nephrol. 2009 Aug;20(8):1714-23. doi: 10.1681/ASN.2008060640. Epub 2009 May 14.
8
Internalization of eNOS and NO delivery to subcellular targets determine agonist-induced hyperpermeability.内皮型一氧化氮合酶的内化以及一氧化氮向亚细胞靶点的传递决定了激动剂诱导的高通透性。
Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6849-53. doi: 10.1073/pnas.0812694106. Epub 2009 Apr 2.
9
Xenon preconditioning protects against renal ischemic-reperfusion injury via HIF-1alpha activation.氙预处理通过激活缺氧诱导因子-1α保护肾脏免受缺血再灌注损伤。
J Am Soc Nephrol. 2009 Apr;20(4):713-20. doi: 10.1681/ASN.2008070712. Epub 2009 Jan 14.
10
Heart mitochondria: gates of life and death.心脏线粒体:生死之门。
Cardiovasc Res. 2008 Jan 15;77(2):334-43. doi: 10.1093/cvr/cvm005. Epub 2007 Aug 21.